Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial

AIMS: Although heart failure (HF) with preserved ejection fraction (HFpEF) is a leading cause for hospitalization, its overall costs remain unclear. Therefore, we assessed the health care‐related costs of ambulatory HFpEF patients and the effect of spironolactone. METHODS AND RESULTS: The aldosteron...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ESC Heart Fail
Main Authors: Hashemi, Djawid, Dettmann, Ludwig, Trippel, Tobias D., Holzendorf, Volker, Petutschnigg, Johannes, Wachter, Rolf, Hasenfuß, Gerd, Pieske, Burkert, Zapf, Antonia, Edelmann, Frank
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7261555/
https://ncbi.nlm.nih.gov/pubmed/31984661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12606
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados